chrisvoncsefalvay/vaers-outcomes huggingface dataset:
dizzy spells; swollen feet; frequent urination; vertigo/room was spinning around me; hypokalemia; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPOKALAEMIA (hypokalemia) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.   Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID], COLECALCIFEROL (VITAMIN D3) and PARACETAMOL (ACETAMINOPHEN) for an unknown indication.  On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced HYPOKALAEMIA (hypokalemia) (seriousness criterion medically significant) and VERTIGO (vertigo/room was spinning around me). On an unknown date, the patient experienced DIZZINESS (dizzy spells), PERIPHERAL SWELLING (swollen feet) and POLYURIA (frequent urination). At the time of the report, HYPOKALAEMIA (hypokalemia), DIZZINESS (dizzy spells), PERIPHERAL SWELLING (swollen feet), POLYURIA (frequent urination) and VERTIGO (vertigo/room was spinning around me) outcome was unknown.   DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Apr-2021, Blood potassium: 2.6 (Low) diagnosed with hypokalemia.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  Treatment for the event hypokalemia included 2 intravenous bag of potassium chloride.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
I woke up on March 30th covered in Hives.  This was 20 days after my first vaccine.  I contacted my primary care physician and he suggest I begin taking either Allegra or Zyrtec.  I then got my second vaccine shot on April 7th. I have been to both an allergist and a dermatologist and they both agree that this is a reaction to the vaccine. They too have prescribed over the counter Allegra or Zyrtec. This is now the 49th straight day that I have had this issue.  At time they are more severe than others, but they have been present in one form or another since March 30th.
Pt experienced a seizure event 1 day after vaccine admin. Has a prior history of seizures only during drug abuse, however states she's been clean for greater than 3 years. Hasn't had seizure since substance abuse period. Pt checked "no" to every question on consent form, indicating she was a candidate for vaccination.
Had severe swelling under the left arm pit that lasted for about 1 week, and a lump roughly the size of a plum. After the lump subsided, then severe joint pain ensued.  Pain has been chronic ever since.  Sometimes effecting the ability to walk. Pain is mainly centered around hips and knees.  On certain days the pain is all over, especially in joints. The joint pain has not gone away.  Treating with Ibuprofen and CBD oil, and other anti-inflammatories.  I absolutely DID NOT have any of this prior to receiving the Covid-19 vaccine.
First got Covid Arm, a few days after vaccine, then a few days later, developed a reverse rash over entire torso.   Went to Urgent Car and was given a prescription for Triamcinolone Acetonide.  Severe rash continued to worsen, and then I saw the dermatologist who gave me a shot of Kenalog in the butte on February 22.  Today is February 25 and the rash is starting to lighten up. x
dizzy spells; night sweats; DECREASE IN APPETITE; decrease in interest; decrease in energy; wakes up frequently; very much pain; Very Tired; shortness of breath; abdominal pain; Back Pain; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), ABDOMINAL PAIN (abdominal pain), BACK PAIN (Back Pain), DIZZINESS (dizzy spells) and NIGHT SWEATS (night sweats) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04ILZOA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Depression, Insomnia on 30-Jun-2017, Erectile dysfunction NOS on 30-Jun-2017 and Vitamin D decreased. Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) from 05-Jun-2019 to an unknown date for Depression, SILDENAFIL CITRATE (VIAGRA CONNECT) from 22-Jan-2021 to an unknown date for Erectile dysfunction, SUVOREXANT (BELSOMRA) from 19-Apr-2021 to an unknown date for Insomnia, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) from 11-Nov-2019 to an unknown date for Vitamin D deficiency.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2021, the patient experienced DYSPNOEA (shortness of breath), ABDOMINAL PAIN (abdominal pain), BACK PAIN (Back Pain), PAIN (very much pain) and FATIGUE (Very Tired). On an unknown date, the patient experienced DIZZINESS (dizzy spells), NIGHT SWEATS (night sweats), DECREASED APPETITE (DECREASE IN APPETITE), MALAISE (decrease in interest), ASTHENIA (decrease in energy) and POOR QUALITY SLEEP (wakes up frequently). At the time of the report, DYSPNOEA (shortness of breath), BACK PAIN (Back Pain), PAIN (very much pain) and FATIGUE (Very Tired) had resolved and ABDOMINAL PAIN (abdominal pain), DIZZINESS (dizzy spells), NIGHT SWEATS (night sweats), DECREASED APPETITE (DECREASE IN APPETITE), MALAISE (decrease in interest), ASTHENIA (decrease in energy) and POOR QUALITY SLEEP (wakes up frequently) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered DIZZINESS (dizzy spells), NIGHT SWEATS (night sweats), DECREASED APPETITE (DECREASE IN APPETITE), MALAISE (decrease in interest), ASTHENIA (decrease in energy) and POOR QUALITY SLEEP (wakes up frequently) to be related. No further causality assessments were provided for DYSPNOEA (shortness of breath), ABDOMINAL PAIN (abdominal pain), BACK PAIN (Back Pain), PAIN (very much pain) and FATIGUE (Very Tired).    concomitant medications include belsomra ,Zoloft ,Viagra, vitamin D.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 19-Jan-2021: No specific follow-up information recorded. On 26-Apr-2021: Significant Events, Concomitant medication ,product information ,medical history was updated.
I broke out in severe hives. This is unusual for me as I do not typically get hives. I am still getting them almost one month later, although they are less severe. The reason I think this may be related to the Moderna booster is that my sister also experienced severe hives starting ten days after her Moderna booster, which is when my started. We do not live near each other and had not seen each other recently, and she had her booster a week after I did in a different state. There is no other connection.
This spontaneous report was received from a Certified Medical Assistant (C.M.A) regarding a 4 year old patient of unspecified gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 20-JUL-2016, the patient was vaccinated with improperly stored PROQUAD (lot # L050910, expiry date 14-JUN-2017) dosing regimen unknown. Call was because of a data logger. It was reported that the vaccine administered was subjected to temperature excursion of 23 degree Celsius for a time frame of 1 hour and 29 minutes. The vaccine was not subjected to any previous temperature excursion. No adverse effect was reported. Product quality complaint (PQC) was not filed. This is one of the several reports received from the same reporter. Additional information has been requested.
Abnormal mammogram on 3/18/2021. Went to clinic for undiagnosed breast cancer screening and was diagnosed with breast cancer on 4/23/2021. The finding was on my left breast. Nothing in the right breast. Mastectomy was performed on both left and right breast. Currently on hormone pills (Tamoxifen)
a patient was given Johnson and Johnson Covid-19 vaccine 7 days after his 1st dose of Moderna covid-19 vaccine; Johnson and Johnson Covid-19 vaccine 7 days after his 1st dose of Moderna; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (a patient was given Johnson and Johnson Covid-19 vaccine 7 days after his 1st dose of Moderna covid-19 vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Johnson and Johnson Covid-19 vaccine 7 days after his 1st dose of Moderna) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (a patient was given Johnson and Johnson Covid-19 vaccine 7 days after his 1st dose of Moderna covid-19 vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Johnson and Johnson Covid-19 vaccine 7 days after his 1st dose of Moderna). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (a patient was given Johnson and Johnson Covid-19 vaccine 7 days after his 1st dose of Moderna covid-19 vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Johnson and Johnson Covid-19 vaccine 7 days after his 1st dose of Moderna) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No  concomitant medical  provided by the reporter. No treatment medication provided by the reporter.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (BNT162B2 OMI XBB.1.5), on 21Sep2023 at 12:00 as dose 1, single (Lot number: HG4629) at the age of 73 years, in right arm for covid-19 immunisation; for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: bnt162b2;bnt162b2 omi ba.4-5 (Dose Number: 6, Batch/Lot No: GJ6772, Location of injection: Left Arm, Vaccine Administration Time: 11:45 AM), administration date: 26Dec2022, when the patient was 72-year-old, for COVID-19 immunization; bnt162b2;bnt162b2 omi ba.4-5 (Dose Number: 5, Batch/Lot No: GH9702, Location of injection: Left Arm, Vaccine Administration Time: 11:00 AM), administration date: 15Sep2022, when the patient was 72-year-old, for COVID-19 Immunization; bnt162b2 (Dose Number: 4, Batch/Lot No: FJ9943, Location of injection: Left Arm, Vaccine Administration Time: 11:00 AM), administration date: 04Apr2022, when the patient was 71-year-old, for COVID-19 Immunization; bnt162b2 (Dose Number: 3, Batch/Lot No: FD8448, Vaccine Administration Time: 03:00 PM), administration date: 17Sep2021, when the patient was 71-year-old, for COVID-19 Immunization; bnt162b2 (Dose Number: 2, Batch/Lot No: ER2613, Vaccine Administration Time: 05:00 PM), administration date: 19Mar2021, when the patient was 70-year-old, for COVID-19 Immunization; bnt162b2 (Dose Number: 1, Batch/Lot No: EN6200, Vaccine Administration Time: 02:00 PM), administration date: 24Feb2021, when the patient was 70-year-old, for COVID-19 Immunization. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 04Oct2023 at 12:00, outcome "recovered" (09Oct2023) and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (04Oct2023) Positive; (09Oct2023) Negative. Therapeutic measures were taken as a result of vaccination failure, covid-19 with Paxlovid.  Clinical course:  Anti-viral details, Paxlovid, treatment started on 04Oct2023  and treatment stopped on 08Oct2023 for treatment of COVID-19. On 04Oct2023, positive test for Covid-19 with mild symptoms, no fever. Negative test  on 09Oct2023 9 AM. The patient had no known allergies.
08/05/2022 I started feeling bad with body aches, headache, and cough. I began having difficulty breathing. I never had a fever, but since then I have had tinnitus. I took a home COVID test which was positive. On 08/06/22 I was tested again with a PCR test which was positive at the clinic, where I work. I saw the doctor and was given PAXLOVID and a SYMBICORT inhaler. I was home sick for a week and it took about a week and a half for the symptoms to go away. However, I still have tinnitus.
2-4 days after immunization, developed "red spot", enlarged over week time to 7cm. Red, round, raised and hot area.
Patient required hospitalization due to breakthrough infection. He received the Pfizer vaccine (2nd dose in series) on 03/06/21. Hospitalized from 08/06/21 - 08/14/21. Below is copied from discharge summary:   Patient is a 65 y/o CM with PMH significant for COPD, PAH, HTN, HLD who presented to ER on 8/6 for concerns of SOB.  He (and his wife) were vaccinated for covid in Feb March 2021.  He was seen by his pulm due to SOB, cough, fatigue on monday 8/2 and tested pos for covid at that time. His pulm gave him a course of oral abx and steroids and he has completed them but was not feeling any better.  He checks his sats regularly at home and found a reading of 64% on 5l NC o2 so called EMS.    Upon arrival to ER he required escalation to HFNC 90%/ 60 l flow and ICU was consulted due to O2 req.    Patient was discharged on 08/14/21.
She said, she is still having extreme hair loss; She was like bald-head; This is a spontaneous report received from a contactable reporter(s) (Nurse).  A female patient received COVID-19 Vaccine - Manufacturer Unknown, as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Covid-19" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: ALOPECIA (non-serious) with onset 2021, outcome "unknown", described as "She was like bald-head"; ALOPECIA (non-serious) with onset Dec2021, outcome "unknown", described as "She said, she is still having extreme hair loss".  Additional information: Reporter stated that, she went to have a doctor's Ophthalmology test last week, she was talking to a girl that was checking my vision and she do not know how we got talking about that but patient told  that she have had a Covid infection and she said that her hair has started to fall out and you know while she was having Covid she was having terrible loss of hair, she was like bald head and after she got better with Covid infection she said that she went took the Covid vaccine, reporter do not know she had Pfizer or Moderna, reporter did not thought to ask her that but she said after she had the Covid infection and then she went and had vaccinated and she said she is still having extreme hair loss after having Covid infection and then having her Covid vaccination after having had a Covid infection.  The information on the batch/lot number for COVID-19 Vaccine - Manufacturer Unknown has been requested and will be submitted if and when received.
To MD 6 hrs /p vax. Mom reports inconsolable crying. Low grade fever. No Rx required. MD order for no further DTP
Falling hair in handfull; sore scalp; Fever; Bodyache; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (Falling hair in handfull), PAIN OF SKIN (sore scalp), PYREXIA (Fever), MYALGIA (Bodyache) and FATIGUE (Tiredness) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 immunisation.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and OMEGA-3-ACID ETHYL ESTER (LOVAZA) for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PYREXIA (Fever), MYALGIA (Bodyache) and FATIGUE (Tiredness). On 24-Feb-2021, the patient experienced ALOPECIA (Falling hair in handfull) and PAIN OF SKIN (sore scalp). At the time of the report, ALOPECIA (Falling hair in handfull), PAIN OF SKIN (sore scalp), PYREXIA (Fever), MYALGIA (Bodyache) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient did not receive any treatment medications.
1 of 2 pts who had an inject site react (significant inflammatory sterile cellulitis); no cultures taken; no evidence of bacterial infection; both pts were vaxed from the same lot#;
On 2/13/2021 around 2000, (name) requested care for rash/blisters that developed on right foot (top and bottom) and back present x 3 days after receiving the Pfizer COVID first dose on 2/8/2021. Patient complained the blisters were tender, burning and itchy. Patient was seen at the Emergency Dept on 2/12/2021 and advised she had a fungus and was given Rx steroid cream, which she states was not helpful. Patient called Dispatch Health to assess her symptoms; Provider diagnosed patient with exanthum related to herpes zoster (shingles) and Rx antiviral (oral) was provided on 2/13/2021.
On 3/22/06, day after injection, pt reported left upper arm swollen, red, and painful. Seen by Dr on 3/23 had low grade fever, instructed to take Benadryl, Motrin and call if S/SX worsen. 3/24 pt advised to go to ER for evaluation. Hospital reports induration increased, pt left arm mobility impaired due to pain. Admitted placed on Vnosyn, not effective, changed to Vancomycin.
Patient received vaccination.  After administration patient stood and waited several minutes for friend to get vaccine.  Upon exiting vaccination room several minutes after vaccine patient fainted and fell to the ground.  Patient quickly revived refusing medical treatment.  Patient admits to being nervous about vaccine and admits after fainting that it happened once before when giving blood.
Pt received her first COVID19 Moderna vaccine, while sitting in observation she reported a tingling sensation in her bottom lip. Pt reports many allergies to medication but none that caused anaphylaxis. Pt was evaluated by EMS. BP 158/96, 162/99 HR 80, O2sat 98%. Pt signed refusal with EMS for transport. Symptoms did not progress while sitting in observation any further.
feeling very cold; both legs felt a bit weak than usual; Mild headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (feeling very cold), MUSCULAR WEAKNESS (both legs felt a bit weak than usual) and HEADACHE (Mild headache) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jun-2021, the patient experienced FEELING COLD (feeling very cold), MUSCULAR WEAKNESS (both legs felt a bit weak than usual) and HEADACHE (Mild headache). At the time of the report, FEELING COLD (feeling very cold), MUSCULAR WEAKNESS (both legs felt a bit weak than usual) and HEADACHE (Mild headache) outcome was unknown.            No concomitant medication was reported.  No treatment medication was reported.  For mRNA-1273 (COVID 19 Vaccine Moderna), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-219706 (Patient Link).
Patient reported redness, slight swelling and warm-to-touch around injection site one day after injection-Local reaction. BENADRYL, cool compress, and NSAID suggested. Three days after reporting reaction had cleared.
Itchy at injection site with raised area AM, then 2? red raised area by evening. Cortisone cream relieved itchiness.
This is a spontaneous report from a contactable healthcare professional via a Pfizer sales representative. A 78-year-old male patient received PREVNAR 13 on 31Jan2017, in right arm, at single dose, for immunisation. Medical history included upset stomach, blood pressure abnormal and cholesterol abnormal. Concomitant medications included lansoprazole once daily for upset stomach, ramipril once daily for blood pressure, atorvastatin for cholesterol, acetylsalicylic acid (ASPIRIN) 81 mg, daily and fish oil.  After the patient had the vaccine, couple of hours later, on 31Jan2017, he got a lump under his skin, it was red and itchy and warm to the touch and there was localised swelling but then it swelled up and took over his whole upper arm. He had no other side effects. The patient visited the Doctor and was better. Treatment received: none. Laboratory tests: none. The final outcome of each reported event was unknown.
vaccine exposure via breast milk; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (vaccine exposure via breast milk) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    MEDICAL HISTORY (Parent): No medical history was provided by reporter.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPOSURE VIA BREAST MILK (vaccine exposure via breast milk). At the time of the report, EXPOSURE VIA BREAST MILK (vaccine exposure via breast milk) outcome was unknown.            No Concomitant medication were provided by reporter  No treatment was reported
Appx 24 hrs after injection. Employee began having itching of bilat legs from just above knees to ankles - itching became progressively worse by AM on 2-7-10 employee had red dot "rash" on bilat legs from above knees to ankles- On 2-8-10  2-9-10 employee took BENADRYL - has no more itching does still have red dot "rash" on legs from ankles to just above knees - Employee reported itching 2-8-10 pm - No trunk or other body involvement.
MAY 8 - 13, NORMAL SIDE EFFECTS.   BRUISE NEAR INJECTION,  TENDERNESS AND MILD PAIN IN WHOLE ARM FROM ARMPIT TO HAND, FATIGUE. ABOUT A WEEK LATER, ON MAY 14, WOKE UP WITH REDNESS NEXT TO THE INJECTION SIDE, ABOUT THE SIZE OF A LEMON, TENDESNEES STARTED GETTING WORSE, THE HIVE STARTED GETTING BIGGER EVERY DAY AND LIFTING MY ARM WAS UNCOMFORTABLE.      ON  MAY 21st, ALMOST TWO WEEKS LATER,  THE HIVE WAS FROM MY SHOLDER TO MY ELBOW SO WENT TO URGENT CARE.   I WAS GIVEN PREDNISONE FOR 5 DAYS, BENADRYL AND NEXIUM.  STARTED TAKING THEM YESTERDAY, MAY 22nd .